Viewing Study NCT01117103


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2026-05-12 @ 5:57 PM
Study NCT ID: NCT01117103
Status: COMPLETED
Last Update Posted: 2014-07-16
First Post: 2010-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes View
None Diabetes Mellitus View
None Glucophage View
None Metformin View